Circ-EPB41L2 is downregulated in the exosomes of CRC patients, and exosome-mediated circ-EPB41L2 suppresses tumor progression by regulating the PTEN/AKT signaling pathway [191]. This evidence concerns the gene EPB41L2 and neoplasm.